The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| FINISAR CORP | COM NEW | 31787A507 | 1,041 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| MELLANOX TECHNOLOGIES LTD | SHS | M51363113 | 42,638 | 360,238 | SH | SOLE | 360,238 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 6,489 | 897,523 | SH | SOLE | 897,523 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 25,760 | 226,200 | SH | SOLE | 226,200 | 0 | 0 | ||
| TRIBUNE MEDIA CO - A | CL A | 896047503 | 2,731 | 59,200 | SH | SOLE | 59,200 | 0 | 0 | ||